Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 18.
doi: 10.1038/s41586-026-10113-6. Online ahead of print.

In vivo base editing of Chd3 rescues behavioural abnormalities in mice

Affiliations

In vivo base editing of Chd3 rescues behavioural abnormalities in mice

Kan Yang et al. Nature. .

Abstract

Neurodevelopmental disorders that arise from de novo mutations in chromatin-remodelling genes lack targeted treatments. Snijders Blok-Campeau syndrome (SNIBCPS)1, which is caused by pathogenic variants in CHD3, manifests with intellectual disability, autistic-like behaviours and motor deficits2. Whether somatic gene correction can reverse such phenotypes in vivo remains unknown. Here we show that modelling the recurrent CHD3 variant p.R1025W in a humanized mouse model (Chd3hR1025W/+) recapitulates key features of SNIBCPS, including reduced CHD3 protein levels and abnormalities in social communication, cognition and motor coordination. We engineered a TadA-embedded adenine base editor (TeABE) and delivered it brain-wide using a dual adeno-associated virus (AAV) system and achieved efficient on-target A•T-to-G•C correction across multiple cortical and hippocampal regions with minimal bystander activity. This intervention restored CHD3 levels and ameliorated behavioural abnormalities in vivo. Furthermore, intrathecal dual AAV delivery in nonhuman primates resulted in widespread neuronal transduction and efficient TeABE reconstitution, a result that supports its translational feasibility. These findings establish in vivo base editing as a viable therapeutic approach for CHD3-related neurodevelopmental disease. More broadly, they demonstrate that precise single-base correction in the postnatal brain can restore protein dosage and function, thereby offering a framework for the treatment of monogenic neurodevelopmental disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Snijders Blok, L. et al. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat. Commun. 9, 4619 (2018). - PubMed - PMC - DOI
    1. Tie, X. et al. Insights from a novel splicing variant and recurrent arginine variants in the CHD3 gene causing Snijders Blok–Campeau syndrome. Am. J. Med. Genet. https://doi.org/10.1002/ajmg.a.63930 (2024).
    1. Gillentine, M. A., Wang, T. & Eichler, E. E. Estimating the prevalence of de novo monogenic neurodevelopmental disorders from large cohort studies. Biomedicines https://doi.org/10.3390/biomedicines10112865 (2022).
    1. Coursimault, J. et al. Hypersociability associated with developmental delay, macrocephaly and facial dysmorphism points to CHD3 mutations. Eur. J. Med. Genet. 64, 104166 (2021). - PubMed - DOI
    1. Mizukami, M. et al. A de novo CHD3 variant in a child with intellectual disability, autism, joint laxity, and dysmorphisms. Brain Dev. 43, 563–565 (2021). - PubMed - DOI

LinkOut - more resources